Cargando…

Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages

CD163 is a marker for alternatively activated macrophages, which have been implicated in the pathogenesis of lupus nephritis (LN). In our preliminary screening of urine proteins in LN, urine soluble CD163 (sCD163) was significantly elevated in patients with active LN. To evaluate the potential of sC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ting, Li, Hao, Vanarsa, Kamala, Gidley, Gabriel, Mok, Chi Chiu, Petri, Michelle, Saxena, Ramesh, Mohan, Chandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174755/ https://www.ncbi.nlm.nih.gov/pubmed/32351512 http://dx.doi.org/10.3389/fimmu.2020.00671

Ejemplares similares

Crescentic Glomerulonephritis with Fibrinoid Vasculitis after Administration of Influenza Vaccine
por: Hara, Risa, et al.
Publicado: (2022)

Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis
por: Soliman, Samar A., et al.
Publicado: (2022)

Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities
por: Stanley, Samantha, et al.
Publicado: (2020)

Author Correction: Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities
por: Stanley, Samantha, et al.
Publicado: (2020)

Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis
por: Singh, Sandeep, et al.
Publicado: (2012)

Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicity
por: Shen, Yiwei, et al.
Publicado: (2023)

Multiple myeloma characterized by synovial fibrinoid necrosis: a case report
por: Liu, You jun, et al.
Publicado: (2021)

Corrigendum: Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicity
por: Shen, Yiwei, et al.
Publicado: (2023)

FIBRINOUS EXUDATES AND FIBRINOID DEGENERATION
por: Gaylord, H. R.
Publicado: (1898)

Neutrophil extracellular trap components in fibrinoid necrosis of the kidney with myeloperoxidase-ANCA-associated vasculitis
por: Yoshida, Masaharu, et al.
Publicado: (2013)

Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy
por: Farag, Azza Gaber Antar, et al.
Publicado: (2020)

Urine Soluble CD163 Is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis
por: Huang, Yun-Ju, et al.
Publicado: (2022)

Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: a prospective study
por: Su, Longxiang, et al.
Publicado: (2012)

Corrigendum: Urine soluble CD163 is a promising biomarker for the diagnosis and evaluation of lupus nephritis
por: Huang, Yun-Ju, et al.
Publicado: (2022)

Clinical significance of sCD163 and its possible role in asthma
por: Zhi, Yue, et al.
Publicado: (2017)

Cetuximab-Associated Crescentic Diffuse Proliferative Glomerulonephritis
por: Manthri, Sukesh, et al.
Publicado: (2017)

Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection
por: Mascia, Claudia, et al.
Publicado: (2018)

Transvitreal and subretinal fibrinoid reaction following diabetic vitrectomy
por: Nelson, Andrew J., et al.
Publicado: (2022)

Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
por: Feng, Lin, et al.
Publicado: (2012)

Regular Training Increases sTWEAK and Its Decoy Receptor sCD163–Does Training Trigger the sTWEAK/sCD163-Axis to Induce an Anti-Inflammatory Effect?
por: Schönbauer, Robert, et al.
Publicado: (2020)

Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology
por: Gómez-Rial, Jose, et al.
Publicado: (2020)

Soluble haemoglobin scavenger receptor (sCD163): a marker associated with bacteraemia
por: Gaïni, S, et al.
Publicado: (2005)

sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis
por: Silva, Ricardo Luís Louzada, et al.
Publicado: (2017)

An unusual case of crescentic lupus nephritis presenting with normal renal function
por: Manohar, Sandhya, et al.
Publicado: (2015)

Crescentic glomerular nephritis associated with rheumatoid arthritis: a case report
por: Balendran, K., et al.
Publicado: (2017)

Treatment of membranous nephropathy with crescent nephritis by rituximab: A case report
por: Zhang, Fan, et al.
Publicado: (2022)

Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus
por: Soliman, Samar A., et al.
Publicado: (2022)

The macrophage low-grade inflammation marker sCD163 is modulated by exogenous sex steroids
por: Thomsen, Henrik H, et al.
Publicado: (2013)

Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma
por: Stuhr, Liva K., et al.
Publicado: (2023)

Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors
por: Castley, Alison, et al.
Publicado: (2016)

Proliferative, necrotizing and crescentic immune complex-mediated glomerulonephritis in a cat
por: Gross, Carolyn, et al.
Publicado: (2015)

Systemic, but not local, low-grade endotoxinemia increases plasma sCD163 independently of the cortisol response
por: Bach, Ermina, et al.
Publicado: (2019)

Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2023)

Dissecting signalling pathways associated with intrarenal synthesis of complement components in lupus nephritis
por: Tampe, Desiree, et al.
Publicado: (2022)

Rapidly Progressive Pauci-Immune Glomerulonephritis with Aberrant Fibrinoid Necrosis Associated with Atezolizumab, an Immune Check Point Inhibitor: A Case Report and Review of Literature
por: Nikolopoulos, Petros, et al.
Publicado: (2023)

Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis
por: Romick-Rosendale, Lindsey E, et al.
Publicado: (2011)

Molecular characterization of proliferative lupus nephritis
por: Parikh, Samir V, et al.
Publicado: (2014)

Urine proteomic insights from the belimumab in lupus nephritis trial
por: Weeding, Emma, et al.
Publicado: (2022)

Is sCD163 a Clinical Significant Prognostic Value in Cancers? A Systematic Review and Meta-Analysis
por: Qian, Shushu, et al.
Publicado: (2020)

Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients
por: Marocco, Raffaella, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hm06fm4uv0ev8qj4rddosvv26b